Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-10

Clinical Trial Update: Artificial-Intelligence-based Early Detection of Diabetic Retinopathy (FUNDUS AI)

View source ↗

Summary

An ongoing University Hospital Tuebingen trial is evaluating FUNDUS AI, an artificial intelligence tool for early detection of diabetic retinopathy in people wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital Tuebingen | Conditions: Diabetes (DM), Prediabetes | Status: ENROLLING_BY_INVITATION